Peripheral Neuropathy outcome after 2-years of treatment with tafamidis in patients with only small fiber symptoms and non-Val30Met hATTR amyloidosis. (1833)

DOI: 10.1212/wnl.94.15_supplement.1833 Publication Date: 2023-12-07T05:28:50Z